Merrimack Pharmaceuticals (NASDAQ: MACK) has recently received a number of price target changes and ratings updates:
Shares of Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) traded down 4.06% during mid-day trading on Monday, hitting $6.15. The company’s stock had a trading volume of 1,492,002 shares. The company’s market cap is $797.13 million. Merrimack Pharmaceuticals Inc. has a 52-week low of $4.39 and a 52-week high of $9.63. The stock’s 50 day moving average price is $5.59 and its 200 day moving average price is $5.67.